114 related articles for article (PubMed ID: 38226993)
1. Mass Spectrometry-Based Proteomics Identifies Serpin B9 as a Key Protein in Promoting Bone Metastases in Lung Cancer.
Huang Y; Gong M; Chen H; Deng C; Zhu X; Lin J; Huang A; Xu Y; Tai Y; Song G; Xu H; Hu J; Feng H; Tang Q; Lu J; Wang J
Mol Cancer Res; 2024 Apr; 22(4):402-414. PubMed ID: 38226993
[TBL] [Abstract][Full Text] [Related]
2. Serpin B9 controls tumor cell killing by CAR T cells.
Kimman T; Slomp A; Martens A; Grabherr S; Li S; van Diest E; Meeldijk J; Kuball J; Minnema MC; Eldering E; Bovenschen N; Sebestyén Z; Peperzak V
J Immunother Cancer; 2023 Mar; 11(3):. PubMed ID: 36931661
[TBL] [Abstract][Full Text] [Related]
3. Overview of serpin B9 and its roles in cancer (Review).
Wang WJ; Wang J; Ouyang C; Chen C; Xu XF; Ye XQ
Oncol Rep; 2021 Sep; 46(3):. PubMed ID: 34278491
[TBL] [Abstract][Full Text] [Related]
4. A Novel Serpin Regulatory Mechanism: SerpinB9 IS REVERSIBLY INHIBITED BY VICINAL DISULFIDE BOND FORMATION IN THE REACTIVE CENTER LOOP.
Mangan MS; Bird CH; Kaiserman D; Matthews AY; Hitchen C; Steer DL; Thompson PE; Bird PI
J Biol Chem; 2016 Feb; 291(7):3626-38. PubMed ID: 26670609
[TBL] [Abstract][Full Text] [Related]
5. Serpinb9 is a marker of antigen cross-presenting dendritic cells.
Mangan MS; Vega-Ramos J; Joeckel LT; Mitchell AJ; Rizzitelli A; Roediger B; Kaiserman D; Weninger WW; Villadangos JA; Bird PI
Mol Immunol; 2017 Feb; 82():50-56. PubMed ID: 28024184
[TBL] [Abstract][Full Text] [Related]
6. Serpinb9 (Spi6)-deficient mice are impaired in dendritic cell-mediated antigen cross-presentation.
Rizzitelli A; Meuter S; Vega Ramos J; Bird CH; Mintern JD; Mangan MS; Villadangos J; Bird PI
Immunol Cell Biol; 2012 Oct; 90(9):841-51. PubMed ID: 22801574
[TBL] [Abstract][Full Text] [Related]
7. Cancer driver gene and non-coding RNA alterations as biomarkers of brain metastasis in lung cancer: A review of the literature.
Karimpour M; Ravanbakhsh R; Maydanchi M; Rajabi A; Azizi F; Saber A
Biomed Pharmacother; 2021 Nov; 143():112190. PubMed ID: 34560543
[TBL] [Abstract][Full Text] [Related]
8. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
9. Lung tumor cells inhibit bone mineralization and osteoblast activity.
Berent TE; Dorschner JM; Craig TA; Drake MT; Westendorf JJ; Kumar R
Biochem Biophys Res Commun; 2019 Nov; 519(3):566-571. PubMed ID: 31537378
[TBL] [Abstract][Full Text] [Related]
10. Expression of Serpin B9 as a Prognostic Factor of Colorectal Cancer.
Vycital O; Pitule P; Hosek P; Kriz T; Treska V; Liska V
Anticancer Res; 2019 Nov; 39(11):6063-6066. PubMed ID: 31704833
[TBL] [Abstract][Full Text] [Related]
11. Construction and validation of a novel web-based nomogram for patients with lung cancer with bone metastasis: A real-world analysis based on the SEER database.
Yin M; Guan S; Ding X; Zhuang R; Sun Z; Wang T; Zheng J; Li L; Gao X; Wei H; Ma J; Huang Q; Xiao J; Mo W
Front Oncol; 2022; 12():1075217. PubMed ID: 36568214
[TBL] [Abstract][Full Text] [Related]
12. Incidence, prognostic factors, and a nomogram of lung cancer with bone metastasis at initial diagnosis: a population-based study.
Zheng XQ; Huang JF; Lin JL; Chen L; Zhou TT; Chen D; Lin DD; Shen JF; Wu AM
Transl Lung Cancer Res; 2019 Aug; 8(4):367-379. PubMed ID: 31555512
[TBL] [Abstract][Full Text] [Related]
13. Direct Tumor Killing and Immunotherapy through Anti-SerpinB9 Therapy.
Jiang L; Wang YJ; Zhao J; Uehara M; Hou Q; Kasinath V; Ichimura T; Banouni N; Dai L; Li X; Greiner DL; Shultz LD; Zhang X; Sun ZJ; Curtin I; Vangos NE; Yeoh ZC; Geffken EA; Seo HS; Liu ZX; Heffron GJ; Shah K; Dhe-Paganon S; Abdi R
Cell; 2020 Nov; 183(5):1219-1233.e18. PubMed ID: 33242418
[TBL] [Abstract][Full Text] [Related]
14. The Impact of Immune Interaction on the Metastatic Infiltration of Colorectal Carcinoma to Lymph Nodes.
Vycital O; Dubova M; Palek R; Hosek P; Branzovsky J; Treska V; Daum O; Liska V
Anticancer Res; 2018 Jul; 38(7):4159-4167. PubMed ID: 29970545
[TBL] [Abstract][Full Text] [Related]
15. Clinical features and prognostic factors of brain metastases from colorectal cancer: a single center experience.
Gao Z; Jin X; Wu S
Int J Colorectal Dis; 2023 Jul; 38(1):198. PubMed ID: 37466736
[TBL] [Abstract][Full Text] [Related]
16. The granzyme B-Serpinb9 axis controls the fate of lymphocytes after lysosomal stress.
Bird CH; Christensen ME; Mangan MS; Prakash MD; Sedelies KA; Smyth MJ; Harper I; Waterhouse NJ; Bird PI
Cell Death Differ; 2014 Jun; 21(6):876-87. PubMed ID: 24488096
[TBL] [Abstract][Full Text] [Related]
17. Systematic review and meta-analysis of lung cancer brain metastasis and primary tumor receptor expression discordance.
Tonse R; Rubens M; Appel H; Tom MC; Hall MD; Odia Y; McDermott MW; Ahluwalia MS; Mehta MP; Kotecha R
Discov Oncol; 2021 Nov; 12(1):48. PubMed ID: 35201504
[TBL] [Abstract][Full Text] [Related]
18. Tumor lineage-specific immune response in brain metastatic disease: opportunities for targeted immunotherapy regimen?
Najjary S; Kros JM; de Koning W; Vadgama D; Lila K; Wolf J; Mustafa DAM
Acta Neuropathol Commun; 2023 Apr; 11(1):64. PubMed ID: 37061716
[TBL] [Abstract][Full Text] [Related]
19. Non-invasive prognostic biomarker of lung cancer patients with brain metastases: Recurrence quantification analysis of heart rate variability.
Li G; Wu S; Zhao H; Guan W; Zhou Y; Shi B
Front Physiol; 2022; 13():987835. PubMed ID: 36148296
[No Abstract] [Full Text] [Related]
20. Glutathione peroxidase 4-dependent glutathione high-consumption drives acquired platinum chemoresistance in lung cancer-derived brain metastasis.
Liu W; Zhou Y; Duan W; Song J; Wei S; Xia S; Wang Y; Du X; Li E; Ren C; Wang W; Zhan Q; Wang Q
Clin Transl Med; 2021 Sep; 11(9):e517. PubMed ID: 34586745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
